全文获取类型
收费全文 | 73784篇 |
免费 | 4627篇 |
国内免费 | 274篇 |
专业分类
耳鼻咽喉 | 1121篇 |
儿科学 | 2110篇 |
妇产科学 | 1429篇 |
基础医学 | 8179篇 |
口腔科学 | 1465篇 |
临床医学 | 7264篇 |
内科学 | 15252篇 |
皮肤病学 | 1208篇 |
神经病学 | 7252篇 |
特种医学 | 2638篇 |
外国民族医学 | 27篇 |
外科学 | 12691篇 |
综合类 | 881篇 |
一般理论 | 97篇 |
预防医学 | 6151篇 |
眼科学 | 1396篇 |
药学 | 4700篇 |
中国医学 | 114篇 |
肿瘤学 | 4710篇 |
出版年
2023年 | 403篇 |
2022年 | 651篇 |
2021年 | 1794篇 |
2020年 | 948篇 |
2019年 | 1595篇 |
2018年 | 1855篇 |
2017年 | 1340篇 |
2016年 | 1374篇 |
2015年 | 1509篇 |
2014年 | 2334篇 |
2013年 | 3272篇 |
2012年 | 4969篇 |
2011年 | 5146篇 |
2010年 | 2814篇 |
2009年 | 2509篇 |
2008年 | 4539篇 |
2007年 | 4796篇 |
2006年 | 4676篇 |
2005年 | 4638篇 |
2004年 | 4378篇 |
2003年 | 4032篇 |
2002年 | 3747篇 |
2001年 | 636篇 |
2000年 | 571篇 |
1999年 | 713篇 |
1998年 | 775篇 |
1997年 | 689篇 |
1996年 | 610篇 |
1995年 | 538篇 |
1994年 | 520篇 |
1993年 | 445篇 |
1992年 | 450篇 |
1991年 | 437篇 |
1990年 | 370篇 |
1989年 | 348篇 |
1988年 | 334篇 |
1987年 | 307篇 |
1986年 | 337篇 |
1985年 | 413篇 |
1984年 | 481篇 |
1983年 | 390篇 |
1982年 | 547篇 |
1981年 | 518篇 |
1980年 | 467篇 |
1979年 | 237篇 |
1978年 | 308篇 |
1977年 | 284篇 |
1976年 | 238篇 |
1975年 | 244篇 |
1974年 | 202篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Alexis A Gintowt Jeffrey J Germer P Shawn Mitchell Joseph D C Yao 《Journal of clinical virology》2005,34(2):155-157
BACKGROUND: The current manual sample processing method recommended for use with the TRUGENE HBV Genotyping Kit (TRUGENE HBV; Bayer HealthCare LLC, Tarrytown, NY) is labor-intensive and may be prone to specimen cross-contamination. Recent evaluations of the MagNA Pure LC (MP; Roche Applied Science, Indianapolis, IN) suggest that it is suitable for automated, contamination-free extraction and purification of viral nucleic acids from large-volume (1.0 mL) serum or plasma specimens. OBJECTIVES: We evaluated the MP Total Nucleic Acid Isolation Kit--Large Volume (Roche Applied Science) in conjunction with TRUGENE HBV to establish the analytical sensitivity (threshold titer) of the assay, in HBV DNA International Units (IU)/mL, for obtaining consistent, interpretable sequence data from TRUGENE HBV. STUDY DESIGN: HBV analytical standards, prepared as 10 replicates (1.0 mL each) at each of the following concentrations: 200, 1000, 5000, and 10,000 IU/mL, were processed by MP and analyzed by TRUGENE HBV according to manufacturer's instructions. Performance of TRUGENE HBV used in conjunction with MP sample processing was evaluated further using 22 clinical serum specimens containing low titers of HBV DNA. RESULTS: All replicates of HBV analytical standards at 1000, 5000, and 10,000 IU/mL yielded interpretable TRUGENE HBV sequences, whereas interpretable sequences were obtained in 90% (9 of 10) of the replicates at 200 IU/mL. TRUGENE HBV sequences were interpretable in 86% (19 of 22) of the clinical specimens studied. CONCLUSIONS: MP sample processing is efficient and suitable for use with TRUGENE HBV. When combined with MP sample processing, TRUGENE HBV yielded interpretable sequences from HBV analytical standards and clinical serum specimens with HBV DNA titers of > or =200 IU/mL. 相似文献
72.
Skoug John W. Borin Marie T. Fleishaker Joseph C. Cooper Anne M. 《Pharmaceutical research》1991,8(12):1482-1488
The mechanism of release from sustained-release adinazolam mesylate tablets was assessed by the Higuchi equation and by analysis of drug release profiles through 60% released using the Peppas equation. Computed values of the diffusional exponent, n, ranged from 0.59 to 0.66. Values of n in this range are consistent with a mixed mechanism of release, with diffusion of drug through the hydrated polymer matrix and relaxation of this matrix being the principal processes controlling release. The rate of in vitro drug release was increased for half tablets relative to whole tablets and is attributed to an increase in the surface to volume ratio of half tablets of about 16%. This increase in surface-to-volume ratio of half tablets was reflected by an increase in the constant, k, from the Peppas equation of 20–23% and by an increase in the slope of Higuchi plots of 12–18% for four lots of tablets. In vivo/in vitro relationships from two bioavailability studies were thoroughly evaluated. Using either a linear or a quadratic relationship, an in vivo/in vitro correlation exists for sustained-release adinazolam mesylate tablets. 相似文献
73.
74.
75.
76.
There is a need to investigate methods by which drinkers canbe made aware of their level of alcohol impairment prior todriving. In the current research, 195 students at various bloodalcohol concentration (BAC) levels participated in an evaluationof three simple sobriety tests: a ruler drop/reaction time task,a balance test and a verbal task. Although self-reported measuresof impairment were the best predictors of BAC, both the rulerdrop and body balance tests accounted for significant portionsof BAC variance. These tasks were also perceived by the studentsas reflecting substantial driving ability. Unfortunately, asBAC increased, poor test performance was less likely to resultin a decision not to drive. These results are discussed in termsof the need to continue studying ways to educate drinkers abouttheir level of alcohol impairment so that they can make informeddrinking/driving decisions. 相似文献
77.
Psychopharmacology of children and adolescents: pharmacokinetics and relationships of plasma/serum levels to response. 总被引:1,自引:0,他引:1
B Geller 《Psychopharmacology bulletin》1991,27(4):401-409
This article reviews data from the literature on pharmacokinetics and on relationships of plasma/serum levels to response in the child and adolescent population. The following topics will be covered: saliva vs. serum monitoring, drug-drug interactions, enzyme induction, and the effect of febrile illnesses on protein binding. Similarity of elimination processes based on manifestations that are genetically determined across age groups will be contrasted to elimination mechanisms that are different for the pediatric group due to age specific developmental considerations. Age related differences in plasma/serum level response relationships will be discussed with respect to study population characteristics and pharmacodynamic implications. 相似文献
78.
Ophira Salomon Joseph Moisseiev Tamara Vilganski Rima Dardik Shimon Kurtz Eva Shpringer David M Steinberg Nurit Rosenberg 《Blood coagulation & fibrinolysis》2006,17(6):485-488
To determine whether polymorphisms of platelet surface glycoprotein associated with arterial thrombosis are risk factors for branch retinal vein occlusion. A case-control study in which 69 patients with branch retinal vein occlusion and 147 controls who attended the eye clinic for nonvascular complications participated. DNA was extracted from whole blood and analyzed for genotyping of platelet glycoprotein polymorphisms by polymerase chain reactions and specific restricted enzymes. No relationship was found between the four platelet glycoprotein polymorphisms i.e. GPIa C807T, VNTR and Kozak of glycoprotein Ibalpha, the HPA-1 of glycoprotein IIIa and the occurrence of branch retinal vein occlusion. The HPA-2 polymorphism was found in 18 out 60 (30%) patients with branch retinal vein occlusion in comparison with 27 out 142 (19%) of controls, with an estimated odds ratio of 1.8 (95% confidence interval, 0.91-3.65). The four platelet glycoprotein polymorphisms are not risk factors for branch retinal vein occlusion and therefore it seems unnecessary to screen those patients for it. A larger study is required, however, to determine whether HPA-2 is a novel risk factor for branch retinal vein occlusion. 相似文献
79.
80.